Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › FTY720 increases CD74 expression and sensitizes cancer cells to anti-CD74 antibody-mediated cell death

FTY720 increases CD74 expression and sensitizes cancer cells to anti-CD74 antibody-mediated cell death

US Patent 8591892 · Granted Nov 26, 2013

Estimated economic value: $5,122,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Systems and methods for hemoclip deployment2025
Tool for hemostasis and tissue approximation2025
Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and de2025
Antibody-drug conjugates and uses thereof2025
Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and de2025
Methods of managing tumor flare in adoptive immunotherapy2024
Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and de2023
Synergistic effect of anti-trop-2 antibody-drug conjugate in combination therapy2022
Combining anti-HLA-DR or anti-Trop-2 antibodies with microtubule inhibitors, PAR2022
Efficacy of anti-Trop-2-SN-38 antibody drug conjugates for therapy of tumors rel2021
Subcutaneous anti-HLA-DR monoclonal antibody for treatment of hematologic malign2021
Immunoconjugates with an intracellularly-cleavable linkage2021